Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Blueprint Medicines Corpo...

    NASDAQ: BPMC · Real-Time Price · USD
    99.84
    0.04 (0.04%)
    At close: May 08, 2025, 11:37 AM

    Blueprint Medicines Revenue

    Blueprint Medicines reported an annual revenue of $508.82M, reflecting a 104.04% growth. For the quarter ending March 31, 2025, Blueprint Medicines generated $149.41M in revenue.
    Revenue (ttm)
    $508.82M
    Revenue Growth
    104.04%
    Price / Sales Ratio
    10.77
    Revenue / Employee
    $746.08K
    Employees
    682
    Market Cap
    6.45B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist